Search

everythinglearnresearchcommunity

for

Search:↓

Subcutaneous trastuzumab improves some symptoms and doesn't harm overall quality of life in breast cancer patients.

Afatinib, neratinib, and zanubrutinib could be effective against KRASG12C-mutant tumors.

A 5% DMSO and 5% BSA mix best preserves rabbit dermal papilla cells during cryopreservation.

Enobosarm may effectively treat androgen receptor-positive breast cancer with fewer side effects.

Lower dosages of 2-(difluoromethyl)-dl-ornithine might reduce side effects, supporting further research.

A multi-drug treatment can effectively clear extensive calcinosis in juvenile dermatomyositis.

YH0618 granules may help prevent hair loss in breast cancer patients undergoing chemotherapy.

Kang-ai injection with platinum-based chemotherapy improves tumor response and immune function while reducing side effects in advanced lung cancer.

Excessive eyelash growth from erlotinib may indicate positive tumor response and help treat madarosis.

Low-dose oral minoxidil improved hair growth when topical treatments failed.

EGFR inhibitors in breast cancer treatment can cause serious skin issues affecting patient quality of life.

Dabrafenib was effective and well tolerated in treating thyroid cancer with a specific mutation.

Aminopterin was somewhat effective in acute lymphoblastic leukemia in children but did not increase survival time.

Reductive stress messes up collagen balance and alters cell signaling in human skin cells, which could help treat certain skin diseases.

A new genetic disorder caused by an ODC1 mutation can be treated with DFMO.

KRT80 may worsen cancer by increasing growth and spread, but its full effects on treatment and outcomes need more research.

Azithromycin and Roxithromycin can remove aging cells and may help with anti-aging.

YH0618 granules may help prevent hair loss in breast cancer patients undergoing chemotherapy.

Some existing medicines show promise as safe treatments to protect against the side effects of radiation therapy.

ODC expression in mouse skin and tumors is varied and can be inhibited by retinoic acid or cycloheximide.

Chemotherapy often causes skin and hair issues, but early management can help improve patient care.

EGFR-targeting cancer drugs can cause skin rashes and other side effects.

BLZ-100 is safe for use in skin cancer surgery and may help identify cancerous tissue.

Roxithromycin, an antibiotic, can increase hair growth and might be used as a treatment for hair loss.

Some drugs can cause serious side effects, like hypoglycemia from mix-ups, skin reactions, or depression, and while penicillamine may help rheumatoid arthritis more than auranofin, it has more severe side effects.

Erosive pustular dermatosis of the scalp can occur about 17 weeks after starting EGFR inhibitors, and early minocycline may help manage it.